VitaNova Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Net Income	0.75	0.85	0.14	-0.02	0.14	-0.05
Stock-Based Compensation	-	0	0	-	-	-
Other Operating Activities	0	0	-	-	-0.15	-
Change in Accounts Receivable	-0.95	-1.27	-	-	-	-
Change in Inventory	0.06	0.09	-0.13	-	-	-
Change in Accounts Payable	0.1	-0.01	0.01	0.01	-	-
Change in Income Taxes	0.23	0.22	0.06	-	-	-
Change in Other Net Operating Assets	0.68	0.3	-0.46	-	0.02	0.01
Operating Cash Flow	0.87	0.19	-0.38	-0.02	0	-0.04
Short-Term Debt Issued	-	-	0	0	0.02	0.04
Total Debt Issued	-0.1	-	0	0	0.02	0.04
Short-Term Debt Repaid	-	-0	-	-	-	-
Total Debt Repaid	-0	-0	-	-	-	-
Net Debt Issued (Repaid)	-0.1	-0	0	0	0.02	0.04
Issuance of Common Stock	-	-	0.96	-	-	-
Financing Cash Flow	-0.1	-0	0.96	0	0.02	0.04
Net Cash Flow	0.76	0.19	0.58	-0.01	0.02	-
Free Cash Flow	0.87	0.19	-0.38	-0.02	0	-0.04
Free Cash Flow Margin	27.09%	7.24%	-65.86%	-48.35%	3.38%	-
Free Cash Flow Per Share	0.10	0.02	-0.11	-0.01	0.00	-0.02
Cash Income Tax Paid	0.02	-	-	0	-	-
Levered Free Cash Flow	0.87	0.09	-0.39	-0.01	-	-
Unlevered Free Cash Flow	0.87	0.1	-0.39	-0.01	-	-
Change in Working Capital	0.12	-0.66	-0.52	0.01	0.02	0.01